Intravenous Immunoglobulin in Children with Streptococcal Toxic Shock Syndrome | Zendy

Samir S. Shah | Zendy; Matt Hall | Zendy; Rajendu Srivastava | Zendy; Anupama Subramony | Zendy; James E. Levin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Intravenous Immunoglobulin in Children with Streptococcal Toxic Shock Syndrome

Author(s) -

Samir S. Shah,

Matt Hall,

Rajendu Srivastava,

Anupama Subramony,

James E. Levin

Publication year - 2009

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/606048

Subject(s) - medicine , interquartile range , propensity score matching , confidence interval , epidemiology , pediatrics , retrospective cohort study

Streptococcal toxic shock syndrome (TSS) is a rare and severe manifestation of group A streptococcal infection. The role of intravenous immunoglobulin (IVIG) for streptococcal TSS in children is controversial. This study aims to describe the epidemiology of streptococcal TSS in children and to determine whether adjunctive therapy with IVIG is associated with improved outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research